ストックスクリーナーアプリを入手
9.855
5.38%
0.475
前日終値:
$9.38
開ける：
$9.5
24時間の取引高:
2.49M
Relative Volume:
0.82
時価総額：
$1.28B
収益：
$628.25M
当期純損益:
$-78.55M
株価収益率:
-15.90
EPS:
-0.62
ネットキャッシュフロー:
$-29.73M
1週間 パフォーマンス:
+7.80%
1か月 パフォーマンス:
+22.34%
6か月 パフォーマンス:
+4.05%
1年 パフォーマンス:
-29.54%
1日の値動き範囲:
$9.50
$9.97
1週間の範囲:
$8.68
$9.97
52週間の値動き範囲:
$4.72
$19.11
Neogenomics Inc Stock (NEO) Company Profile
NEO を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
NEO
Neogenomics Inc
|
9.8799 | 1.21B | 628.25M | -78.55M | -29.73M | -0.62 |
|
TMO
Thermo Fisher Scientific Inc
|
526.79 | 198.56B | 43.21B | 6.58B | 6.17B | 17.28 |
|
DHR
Danaher Corp
|
206.32 | 147.61B | 24.01B | 3.41B | 4.86B | 4.7082 |
|
IDXX
Idexx Laboratories Inc
|
638.64 | 50.96B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
138.63 | 39.13B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
204.14 | 34.81B | 15.70B | 1.24B | 2.01B | 6.9036 |
Neogenomics Inc Stock (NEO) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-07-30 | ダウングレード | BTIG Research | Buy → Neutral |
| 2025-07-29 | ダウングレード | William Blair | Outperform → Mkt Perform |
| 2025-05-15 | 開始されました | Guggenheim | Neutral |
| 2025-04-30 | ダウングレード | Leerink Partners | Outperform → Market Perform |
| 2025-01-13 | ダウングレード | The Benchmark Company | Buy → Hold |
| 2024-12-10 | 開始されました | Jefferies | Buy |
| 2024-05-01 | 再開されました | Craig Hallum | Buy |
| 2023-12-29 | 繰り返されました | BTIG Research | Buy |
| 2023-08-21 | アップグレード | Stephens | Equal-Weight → Overweight |
| 2023-05-16 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2023-05-09 | アップグレード | BTIG Research | Neutral → Buy |
| 2023-02-24 | アップグレード | The Benchmark Company | Hold → Buy |
| 2023-02-01 | アップグレード | Needham | Hold → Buy |
| 2022-08-26 | ダウングレード | The Benchmark Company | Buy → Hold |
| 2022-08-22 | ダウングレード | Needham | Buy → Hold |
| 2022-06-03 | 開始されました | Piper Sandler | Overweight |
| 2022-03-29 | ダウングレード | BofA Securities | Buy → Neutral |
| 2022-03-29 | ダウングレード | Stephens | Overweight → Equal-Weight |
| 2022-01-18 | 再開されました | Stephens | Overweight |
| 2021-12-16 | 開始されました | Cowen | Outperform |
| 2021-11-05 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2021-10-14 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2021-06-03 | 開始されました | Goldman | Buy |
| 2021-02-25 | 再開されました | Needham | Buy |
| 2021-02-25 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2021-01-28 | 開始されました | Truist | Buy |
| 2020-12-11 | 再開されました | BTIG Research | Buy |
| 2020-10-28 | 繰り返されました | Needham | Buy |
| 2020-09-09 | 開始されました | Morgan Stanley | Overweight |
| 2020-08-28 | 開始されました | Guggenheim | Buy |
| 2020-07-29 | 繰り返されました | Needham | Buy |
| 2020-06-25 | 開始されました | BofA/Merrill | Buy |
| 2020-04-21 | 再開されました | Stephens | Overweight |
| 2020-03-02 | 再開されました | Craig Hallum | Buy |
| 2020-02-28 | アップグレード | First Analysis Sec | Outperform → Strong Buy |
| 2020-01-23 | ダウングレード | First Analysis Sec | Strong Buy → Outperform |
| 2019-10-30 | 繰り返されました | Needham | Buy |
| 2019-05-01 | 繰り返されました | Needham | Buy |
| 2019-03-29 | 繰り返されました | Needham | Buy |
| 2019-01-03 | 開始されました | Needham | Buy |
| 2018-10-24 | アップグレード | First Analysis Sec | Outperform → Strong Buy |
| 2018-08-21 | 開始されました | Leerink Partners | Outperform |
| 2018-05-02 | ダウングレード | First Analysis Sec | Overweight → Equal-Weight |
| 2017-09-11 | ダウングレード | BTIG Research | Buy → Neutral |
| 2017-08-24 | 開始されました | Gabelli & Co | Buy |
| 2016-12-15 | 開始されました | Cantor Fitzgerald | Overweight |
すべてを表示
Neogenomics Inc (NEO) 最新ニュース
How NeoGenomics Inc. stock compares to growth peersQuarterly Risk Review & Weekly Return Optimization Alerts - newser.com
Measuring NeoGenomics Inc.’s beta against major indicesQuarterly Earnings Summary & Reliable Momentum Entry Alerts - newser.com
How hedge fund analytics apply to NeoGenomics Inc. stockJuly 2025 Price Swings & Verified Trade Idea Suggestions - newser.com
Is NeoGenomics Inc. stock affected by interest rate hikesEarnings Overview Summary & Consistent Growth Stock Picks - newser.com
Will NeoGenomics Inc. stock gain from government policiesTrade Performance Summary & High Win Rate Trade Alerts - newser.com
Is NeoGenomics Inc. stock bottoming outJuly 2025 Review & Real-Time Market Sentiment Alerts - newser.com
Earnings visualization tools for NeoGenomics Inc.2025 Investor Takeaways & AI Powered Market Entry Ideas - newser.com
NeoGenomics to Highlight RaDaR ST MRD Assay at ESMO Congress 2025 - BioSpace
Visualizing NeoGenomics Inc. stock with heatmapsJuly 2025 Setups & Verified Swing Trading Watchlists - newser.com
NeoGenomics unveils RaDaR ST at ESMO Congress 2025 - Traders Union
How to track smart money flows in NeoGenomics Inc.Bond Market & Capital Efficient Trading Techniques - newser.com
Published on: 2025-10-13 23:26:51 - newser.com
Forecasting NeoGenomics Inc. price range with options dataJuly 2025 Catalysts & Safe Entry Momentum Stock Tips - newser.com
Is NeoGenomics Inc. (NG9) stock good for wealth creation2025 Geopolitical Influence & Growth Focused Entry Reports - newser.com
Volatility clustering patterns for NeoGenomics Inc.July 2025 Levels & Verified Swing Trading Watchlist - newser.com
Published on: 2025-10-13 09:16:58 - newser.com
Regression analysis insights on NeoGenomics Inc. performanceExit Point & AI Driven Stock Movement Reports - newser.com
NeoGenomics rallies after court win in Natera patent dispute - MSN
NeoGenomics unveils Paletrra revolutionizing spatial proteomics - Traders Union
NeoGenomics' (NEO) Sell (D-) Rating Reiterated at Weiss Ratings - MarketBeat
What catalysts could drive NeoGenomics Inc. stock higher2025 Support & Resistance & Weekly Momentum Stock Picks - newser.com
Volume spikes in NeoGenomics Inc. stock – what they meanJobs Report & Verified Chart Pattern Signals - newser.com
Is NeoGenomics Inc. forming a bottoming baseEarnings Recap Report & Weekly Watchlist for Consistent Profits - newser.com
Is NeoGenomics Inc a good long term investmentMarket Liquidity Analysis & Options Trading Analysis Tools - earlytimes.in
United States Pathological Examination Market Growth & - openPR.com
NeoGenomics to Report Third Quarter 2025 Financial Results on October 28, 2025 - BioSpace
Press Release: NeoGenomics to Report Third Quarter 2025 Financial Results on October 28, 2025 - 富途牛牛
NeoGenomics Inc Stock Analysis and ForecastTrading Volume Surges & Outstanding Portfolio Tips - earlytimes.in
What valuation multiples suggest for NeoGenomics Inc. stock2025 Buyback Activity & Safe Capital Growth Stock Tips - newser.com
Piper Sandler Maintains NeoGenomics(NEO.US) With Buy Rating, Maintains Target Price $11 - 富途牛牛
NeoGenomics (NASDAQ:NEO) Sees Unusually-High Trading VolumeTime to Buy? - MarketBeat
agilon health, Tandem Diabetes, NeoGenomics, Hims & Hers Health, and Oscar Health Stocks Trade Up, What You Need To Know - The Globe and Mail
Neogenomics Inc (NEO) 財務データ
収益
当期純利益
現金流量
EPS
0.23%
1.26%
大文字化:
|
ボリューム (24 時間):